Menu
RMS Foundation, Bettlach, Switzerland
Dr. Marc Bohner holds a MSc and PhD degree from the Swiss Federal Institute of Technology of Lausanne (1990, 1993). His career included positions as postdoctoral fellow at the University of Utah, and the Swiss Federal Institute of Technology of Zurich. In 1998, he joined RMS Foundation, a private research and testing lab located in Bettlach, Switzerland. Currently, he serves as a research director and leads the âBioceramic & Biocompatibility Groupâ. His interests include the synthesis, production, and use of calcium phosphates for bone repair.
He holds over fifteen distinct patents, is the inventor of 4 commercial products, and has published and presented widely in his field (â130 articles; h = 50-60). He has given 140 invited lectures in English, French, and German. His teaching positions have included adjunct and affiliated appointments at the University of Sherbrooke (2004 â 2019), the University of Berne (2011 – present), and ETH Zurich (2009 – present).
His services to the scientific community include: Editor of Acta Biomaterialia (2008 Ă ; IF = 10.6); Co-chair of the annual congress of the European Society for Biomaterials (2009); Secretary, vice-president and president of the Swiss Society for Biomaterials (2004 â 2012); Secretary and president of âGRIBOIâ (2007 â 2016); Secretary and then treasurer of the European Society for Biomaterials (2013 â 2021); Member of the Research Council of the Swiss National Science Foundation (2016 â present). In 2013, he received a âhonorary life membershipâ from the Swiss Society for Biomaterials. In 2014, he was awarded the âRacquel LeGeros Awardâ of the âInternational Society for Ceramics in Medicineâ for his contribution to calcium phosphate research. In 2016, he became âhonorary presidentâ of GRIBOI.
RMS Foundation, Bettlach, Switzerland
Nicola Döbelin studied Earth Sciences at the University of Bern, Switzerland, from 1998 to 2002. In 2000 he spent three months in South Africa for a field work project before receiving his Masterâs degree in 2002 for a thesis on the thermal stability of ion-exchanged natural zeolites studied by single-crystal X-ray diffraction. From 2002 to 2006 he worked on his PhD thesis on ion exchange in synthetic titanosilicate phases under supervision of Prof. Thomas Armbruster at the University of Bern. During this time, he became an expert on X-ray powder diffraction and Rietveld refinement. After receiving his PhD in 2006, Nicola started working as a senior scientist at RMS Foundation in Bettlach, Switzerland, with a focus on research, development, and characterization of bioceramics, specifically of calcium phosphate bone-graft substitutes. In 2010 he became deputy quality manager at RMS and specialized on validation of analytical methods. From 2015 to 2019 he took a part-time position as a senior lecturer at the Institute of Geological Sciences, University of Bern. Since 2016, Nicola leads the bioceramics team at RMS. Thanks to his many years of research on synthetic bone graft substitutes, he is now a recognized expert for the synthesis and characterization of calcium phosphate bioceramics.
Senior researcher at RMS Foundation, Bettlach, Switzerland
Dr. Yassine Maazouz holds an MSc from the European School of Material Science and Engineering (EEIGM, Université de Lorraine, France) and a PhD degree in Materials Science from the UPC (Technical University of Catalonia, Spain). His PhD dealt with low temperature 3D printed calcium phosphate scaffold by robocasting. He is an expert on calcium phosphate based bone graft substitutes and is trained and experienced in both academic and industrial R&D. His experience ranges from material science to preclinical and clinical research on biomaterials. He is co-author of more than 19 articles and participated in many international conferences as speaker. Yassine Maazouz is co-founder of Mimetis Biomaterials a spin-off company of the UPC that was recently sold to the Swiss based dental implant multinational Nobel Biocare AG; he has acted as CTO and member of the board of directors of the company for 5 years and has extensive experience in bone graft substitutes development and certification (2 products placed on the European market). He is now a senior researcher at RMS Foundation involved in product development in collaboration with medical device manufacturers.
RMS Foundation, Bettlach, Switzerland
Christoph StÀhli obtained a B.Sc. and M.Sc. in Materials Science from the Swiss Federal Institute of Technology in Lausanne (EPFL) and a Ph.D. from McGill University in Montreal, Canada, where his research focussed on the angiogenic potential of copper-doped bioactive glasses in tissue engineering applications. He also holds a CAS in Management of Biotech, Medtech & Pharma Ventures from EPFL. At RMS Foundation since 2015, he provides materials testing and consulting services to customers from the MedTech industry and develops new analytical methods tailored to meet regulatory requirements of medical devices. In parallel, he conducts research on the physicochemical properties of synthetic calcium phosphate bone substitute materials, with a focus on crystalline structures and their transformations during sintering. He is (co-)author of more than 15 peer-reviewed publications.
October 10, 2023
October 11, 2023
October 17-20, 2023
03 September 2023
October 16-17, 2023
If you are contacted from an email address that you do not recognise regarding any request for payments for Bioceramcs 33 or GRIBOI (e.g. boardassocexecs, or associationbody), please note that they are not operating on our behalf. Please DO NOT respond to the email and delete it immediately.
If you are contacted from any other hotel agency regarding hotel rooms for Bioceramics 33 or GRIBOI 2023 (e.g. from travellerspoint,org ehotelservices / expoforhotelservices, Larry Ellison or EHS), please note that they are not operating on our behalf. We collaborate with HRS and/or hotels directly (see Menu point Accommodation).
